Sign in

CIK 0001069899

  • Large accelerated filer

PHIBRO ANIMAL HEALTH CORP

Sign in to watch
Ticker
PAHC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Jun 30
Incorporated
DE
Entity type
Operating
EIN
131840497
Phone
+1 201-329-7300
Business address
GLENPOINTE CENTRE EAST, 3RD FLOOR, 300 FRANK W. BURR BLVD., SUITE 21, TEANECK, NJ, 07666
Former names
PHILIPP BROTHERS CHEMICALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 5 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-08-06 David Glenn Chief Financial Officer Grant or award +3,482 54,959
2026-08-06 Miller Larry Lee Chief Operating Officer Grant or award +3,726 38,275
2026-08-06 Rodriguez Patrick VP Finance and Treasurer Grant or award +1,503 1,503
2026-08-06 David Glenn Chief Financial Officer Grant or award +3,334 54,811
2026-08-06 Miller Larry Lee Chief Operating Officer Grant or award +3,522 38,071
2026-08-06 BENDHEIM Jonathan Director Grant or award +2,716 5,984
2026-08-06 Weinstein Judith Grant or award +2,478 5,453
2026-08-06 BENDHEIM JACK Executive Chairman Grant or award +12,103 26,640
2026-08-06 Escudero Lisa Ann Grant or award +1,547 3,434
2026-08-06 Bendheim Daniel M President and CEO Grant or award +11,699 15,177
2026-08-04 BENDHEIM JACK Executive Chairman Other disposition −2,303 $36.60 $84K 14,537
2026-08-04 Escudero Lisa Ann Other disposition −265 $36.60 $10K 1,887
2026-08-04 Miller Larry Lee Chief Operating Officer Other disposition −635 $36.60 $23K 34,549
2026-08-04 Weinstein Judith Other disposition −472 $36.60 $17K 2,975
2026-08-04 David Glenn Chief Financial Officer Other disposition −840 $36.60 $31K 51,477
2026-08-04 Bendheim Daniel M President and CEO Other disposition −486 $36.60 $18K 3,478
2026-07-01 Bendheim Daniel M President and CEO Grant or award · Performance Stock Units +300,000 300,000
2026-05-29 CORCORAN E THOMAS Director Purchase +10,000 $31.77 $318K 41,459
2026-05-07 BENDHEIM JACK President and CEO Sale 10b5-1 −1,350 $47.59 $64K 59,330
2026-05-07 BENDHEIM JACK President and CEO Sale 10b5-1 −1,149 $48.31 $56K 58,181

Page 1 of 64 · 1,273 trades